Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (131-140 of 348) with videos related to

Pageof 35
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 5, 2015
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)Masatoshi Kudo, Kazuomi Ueshima, Shoji Kubo, et al.
World Journal of Surgery|December 3, 2003
Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantationChihiro Kosugi, Junji Furuse, Hiroshi Ishii, et al.
American Journal of Clinical Oncology|April 26, 2003
Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Mitsuo Satake, et al.
Journal of Gastroenterology|March 3, 2016
Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance studyShuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki, et al.
Annals of Surgical Oncology|July 28, 2023
Correction: A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT)Shin Kobayashi, Masafumi Ikeda, Kohei Nakachi, et al.
Case Reports in Gastroenterology|February 21, 2025
Steroid-Refractory Immune-Related Hepatitis Caused by Pembrolizumab with Stage IVB Non-Small Cell Lung Cancer: A Case ReportTomomi Hamaguchi, Makoto Ueno, Satoshi Kobayashi, et al.
Japanese Journal of Clinical Oncology|June 28, 2024
Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE)Yusuke Sano, Masashi Kanai, Chigusa Morizane, et al.
Cancers|February 13, 2025
Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical PracticeJunji Furuse, Namiki Izumi, Kenta Motomura, et al.
International Journal of Clinical Oncology|November 22, 2023
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective studyShuhei Nagashima, Satoshi Kobayashi, Shotaro Tsunoda, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2018
An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumorsJunji Furuse, Takayasu Kurata, Naohiro Okano, et al.
Pageof 35

Showing results (131-140 of 348) with videos related to

Sort By:
Pageof 35
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 5, 2015
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)Masatoshi Kudo, Kazuomi Ueshima, Shoji Kubo, et al.
World Journal of Surgery|December 3, 2003
Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantationChihiro Kosugi, Junji Furuse, Hiroshi Ishii, et al.
American Journal of Clinical Oncology|April 26, 2003
Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Mitsuo Satake, et al.
Journal of Gastroenterology|March 3, 2016
Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance studyShuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki, et al.
Annals of Surgical Oncology|July 28, 2023
Correction: A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT)Shin Kobayashi, Masafumi Ikeda, Kohei Nakachi, et al.
Case Reports in Gastroenterology|February 21, 2025
Steroid-Refractory Immune-Related Hepatitis Caused by Pembrolizumab with Stage IVB Non-Small Cell Lung Cancer: A Case ReportTomomi Hamaguchi, Makoto Ueno, Satoshi Kobayashi, et al.
Japanese Journal of Clinical Oncology|June 28, 2024
Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE)Yusuke Sano, Masashi Kanai, Chigusa Morizane, et al.
Cancers|February 13, 2025
Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical PracticeJunji Furuse, Namiki Izumi, Kenta Motomura, et al.
International Journal of Clinical Oncology|November 22, 2023
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective studyShuhei Nagashima, Satoshi Kobayashi, Shotaro Tsunoda, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2018
An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumorsJunji Furuse, Takayasu Kurata, Naohiro Okano, et al.
Pageof 35